SureTrader
Home > Boards > US Listed > Biotechs > Anavex Life Sciences Corp (AVXL)

We don't know what the MTA allowed.

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
powerwalker Member Profile
 
Followed By 13
Posts 2,255
Boards Moderated 0
Alias Born 06/17/09
160x600 placeholder
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/14/2018 5:49:32 PM
Anavex Life Sciences to Present at the 2018 BIO CEO & Investor Conference GlobeNewswire Inc. - 2/8/2018 7:00:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 2/7/2018 5:05:16 PM
Anavex Life Sciences Provides Clinical Programs Update and Reports Fiscal First Quarter 2018 Financial Results GlobeNewswire Inc. - 2/7/2018 7:00:00 AM
Anavex Life Sciences to Announce Fiscal First Quarter 2018 Financial Results and Provide an Update on Clinical Programs and C... GlobeNewswire Inc. - 2/5/2018 7:00:00 AM
Anavex Life Sciences to Present at the Noble Capital Markets 14th Annual Institutional Investor Conference GlobeNewswire Inc. - 1/24/2018 7:00:00 AM
Anavex Life Sciences Reports Potential Normalization of Hypertension with ANAVEX®2-73 Published in The Journal of Clinical H... GlobeNewswire Inc. - 1/16/2018 7:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 12/15/2017 4:13:15 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 12/15/2017 4:11:28 PM
Annual Report (10-k) Edgar (US Regulatory) - 12/11/2017 5:17:35 PM
Anavex Life Sciences Reports Fiscal 2017 Financial Results And Provides Update On Therapeutic Programs GlobeNewswire Inc. - 12/11/2017 7:00:00 AM
Anavex Life Sciences Reports Newly Published Data on Alzheimer's Disease Research Demonstrate the Neuroprotective Features of... GlobeNewswire Inc. - 11/21/2017 7:00:00 AM
Anavex Life Sciences to Present at the 5th Annual Mental Health Parity Addiction Equity Act Business Roundtable in Washington... GlobeNewswire Inc. - 11/8/2017 7:00:00 AM
Anavex Life Sciences Presents New Clinical Data of Investigational Alzheimer’s Disease Treatment ANAVEX®2-73 at 2017 Clini... GlobeNewswire Inc. - 11/4/2017 3:30:00 PM
Greenbank Cap, Inc. (OTC Pink: GRNBF) Closes Private Placement as Shares Climb InvestorsHub NewsWire - 10/30/2017 7:00:00 AM
Anavex Life Sciences Announces Additional Data at The Michael J. Fox Foundation’s Parkinson's Disease Therapeutics Conferen... GlobeNewswire Inc. - 10/30/2017 7:00:00 AM
Anavex Life Sciences Announces New Data Related to Multiple Sclerosis Presented at 7th ECTRIMS-ACTRIMS Meeting MSPARIS2017 GlobeNewswire Inc. - 10/27/2017 8:52:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/26/2017 2:50:54 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/24/2017 12:06:59 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/19/2017 6:47:52 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/18/2017 9:47:41 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/16/2017 11:07:52 AM
Anavex Life Sciences Reports PK and PD Data from Phase 2a Trial of ANAVEX®2-73 in Mild-to-Moderate Alzheimer’s Disease Pat... GlobeNewswire Inc. - 10/12/2017 7:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/6/2017 5:18:01 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/5/2017 5:57:37 PM
powerwalker   Saturday, 08/12/17 08:55:35 PM
Re: A_Good_Day_2 post# 115247
Post # of 142257 
We don't know what the MTA allowed. As noted previously months ago in a post, not all trials are publicized, especially if it is of significance. So, Biogen could have expanded its scope of discovery to perform some human testing ... thus, Dr. M's remark that Biogen is doing additional testing.

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist